NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00264-7510-20 — Dextrose 5% intravenous solutionAI (741 hospitals, 89,935–92,680 samples)
• NDC 23155-0166-41 — Tranexamic acid intravenous solutionAI (487 hospitals, 89,127–92,322 samples)
• NDC 36000-0012-25 — Ondansetron 4 mg/2 mL injection solutionAI (597 hospitals, 83,158–91,960 samples)
• NDC 00000-0025-59 — BUPIVACAINE 0.5% SNGL LUMEN SNGL RATE ON-Q PUMP 550 ML (3 hospitals, 90,302–90,311 samples)
• NDC 63323-0269-69 — Propofol intravenous emulsion, 1000 mg per 100 mLAI (372 hospitals, 84,376–89,506 samples)
• NDC 63323-0492-04 — Lidocaine hydrochloride 1% preservative-free injectionAI (474 hospitals, 72,486–89,037 samples)
• NDC 00641-6030-01 — Fentanyl citrate injection, preservative-free, 2500 mcg per 50 mLAI (587 hospitals, 63,714–88,383 samples)
• NDC 65862-0707-55 — Amoxicillin 250 mg/5 mL oral liquidAI (174 hospitals, 87,433–87,919 samples)
• NDC 00069-0234-01 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (231 hospitals, 85,996–87,715 samples)
• NDC 25021-0608-50 — Propofol intravenous emulsion, 500 mg/50 mLAI (378 hospitals, 84,949–87,487 samples)
• NDC 55150-0168-30 — Bupivacaine 0.25% numbing injectionAI (802 hospitals, 76,129–87,370 samples)
• NDC 00019-1323-06 — Iohexol 320 contrast dye, intravenous solutionAI (157 hospitals, 83,898–86,841 samples)
• NDC 78206-0187-99 — Adalimumab-bwwd 40 mg injection penAI (40 hospitals, 86,475 samples)
• NDC 00019-1323-78 — Ioversol 320 contrast injection, intravenous syringeAI (57 hospitals, 85,148–86,183 samples)
• NDC 55150-0161-02 — Lidocaine 1% injectionAI (719 hospitals, 74,969–85,697 samples)
• NDC 63323-0269-70 — Propofol injectable emulsion, 200 mg per 20 mLAI (205 hospitals, 84,912–85,434 samples)
• NDC 67457-0423-00 — Dexamethasone sodium phosphate 4 mg/mL injectionAI (644 hospitals, 72,632–85,394 samples)
• NDC 23155-0548-31 — Ondansetron (anti-nausea) injection, 4 mg/2 mLAI (233 hospitals, 76,152–84,126 samples)
• NDC 00264-7800-09 — Sodium chloride 0.9% IV solutionAI (426 hospitals, 77,060–82,712 samples)
• NDC 63323-0162-01 — Ketorolac tromethamine 30 mg/mL injectionAI (993 hospitals, 73,182–82,281 samples)
• NDC 70069-0021-01 — Dexamethasone sodium phosphate 10 mg/mL injectionAI (662 hospitals, 64,909–82,099 samples)
• NDC 00641-6027-25 — Fentanyl citrate injection, 100 mcg per 2 mLAI (739 hospitals, 54,010–81,046 samples)
• NDC 00264-7865-00 — Potassium chloride in saline IV solutionAI (553 hospitals, 78,998–81,041 samples)
• NDC 00409-9094-12 — Fentanyl citrate injection, 100 mcg per 2 mLAI (573 hospitals, 60,819–80,628 samples)
• NDC 63323-0161-00 — Ketorolac 15 mg/mL injectionAI (487 hospitals, 74,189–80,561 samples)
• NDC 72266-0118-01 — Ketorolac pain medication injection, 30 mg/mLAI (598 hospitals, 72,518–80,447 samples)
• NDC 63323-0434-41 — Intravenous acetaminophen 1,000 mg solutionAI (556 hospitals, 79,406–80,063 samples)
• NDC 00006-5423-12 — Sugammadex sodium injection 200 mg/2 mLAI (1018 hospitals, 75,216–79,770 samples)
• NDC 00270-1316-41 — Iopamidol 370 contrast dye injectionAI (99 hospitals, 76,765–78,187 samples)
• NDC 63323-0464-37 — Sensorcaine-MPF 0.25% injection solutionAI (570 hospitals, 67,492–77,338 samples)
• NDC 00409-3795-19 — Ketorolac tromethamine injection 30 mg/mLAI (410 hospitals, 72,349–76,966 samples)
• NDC 25021-0701-01 — Ketorolac tromethamine 30 mg/mL injectionAI (521 hospitals, 67,515–76,317 samples)
• NDC 63323-0492-57 — Xylocaine (lidocaine) 1% injection solutionAI (876 hospitals, 63,013–76,117 samples)
• NDC 65219-0383-04 — Iodixanol 320 mg/mL intravenous contrast solutionAI (140 hospitals, 75,071–75,503 samples)
• NDC 23155-0547-42 — Ondansetron injection 4 mg per 2 mLAI (546 hospitals, 64,355–75,182 samples)
• NDC 00641-6027-01 — Fentanyl citrate injection, preservative-free, 100 mcg per 2 mLAI (609 hospitals, 49,623–75,048 samples)
• NDC 00641-0367-21 — Dexamethasone sodium phosphate injectionAI (628 hospitals, 60,327–74,790 samples)
• NDC 00338-0069-10 — Ketorolac tromethamine 15 mg/mL injectionAI (472 hospitals, 70,638–74,337 samples)
• NDC 72266-0118-25 — Ketorolac tromethamine 30 mg/mL injectionAI (704 hospitals, 68,459–74,066 samples)
• NDC 63323-0468-37 — Sensorcaine with epinephrine local anesthetic injectionAI (758 hospitals, 71,849–73,802 samples)
• NDC 63323-0161-01 — Ketorolac injection 15 mg per mLAI (804 hospitals, 66,346–73,762 samples)
• NDC 00069-0234-20 — Propofol IV infusion, 10 mg/mLAI (254 hospitals, 71,646–73,716 samples)
• NDC 00409-3515-01 — Vancomycin 1.5 gram IV solutionAI (391 hospitals, 72,802–73,576 samples)
• NDC 00409-1746-10 — Marcaine with epinephrine injection, 0.25%AI (562 hospitals, 71,415–73,224 samples)
• NDC 00409-6629-02 — Succinylcholine chloride injectionAI (621 hospitals, 70,287–73,104 samples)
• NDC 00990-7074-26 — Potassium chloride IV solution, 10 mEq per 100 mLAI (625 hospitals, 71,350–72,862 samples)
• NDC 00409-4699-53 — Propofol injectable anesthesia medication, 10 mg/mLAI (289 hospitals, 70,890–72,762 samples)
• NDC 63323-0492-07 — Lidocaine 1% injection, preservative-freeAI (444 hospitals, 60,985–72,739 samples)
• NDC 63323-0468-02 — Bupivacaine with epinephrine injectionAI (404 hospitals, 71,581–72,688 samples)
• NDC 00409-1005-01 — Heparin in sodium chloride IV solutionAI (283 hospitals, 70,106–72,428 samples)